Abstract
Cyanobacterial metabolites have proven to be invaluable as tools in thedissection of signal transduction pathways in mammalian cells and some arecurrently under clinical evaluation as drug candidates. It is now also realizedthat cyanobacteria are the true biosynthetic origin of many bioactive moleculesisolated from marine invertebrates; marine invertebrates may sequestercyanobacteria through diet or by symbiosis. This review discusses thedietary-derived cyanobacterial origin of the dolastatins, potent cytotoxiccompounds, originally isolated from the Indian Ocean sea hare,Dolabella auricularia. A discussion on the dietarydissemination of cyanobacterial metabolites through the marine food chain isalso presented. Reference to the metabolites isolated fromDysidea sponges is given to illustrate their origin fromsymbiotic cyanobacteria associated with this organism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Biskupiak J.E. and Ireland C.M. 1984. Revised absolute configuration of dysidenin and isodysidenin. Tetrahedron Letts. 25: 2935-2936.
Carmeli S., Moore R.E. and Patterson G.M.L. 1990. Tolytoxin and new scytophycins from three species of Scytonema. J. Nat. Prod. 53: 1533-1542.
Carter D.C., Moore R.E., Mynderse J.S., Niemczura W.P. and Todd J.S. 1984. Structure of majusculamide C a cyclic depsipeptide from Lyngbya majuscula. J. Org. Chem. 49: 236-241.
Faulkner D.J. 2000. Marine natural products. Nat. Prod. Rep. 17: 7-55.
Harrigan G.G., Yoshida W.Y., Moore R.E., Nagle D.G., Park P.U., Biggs J. et al. 1998a. Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages. J. Nat. Prod. 61: 1221-1225.
Harrigan G.G., Luesch H., Yoshida W.Y., Moore R.E., Nagle D.G., Paul V.J. et al. 1998b. Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides. J. Nat. Prod. 61: 1075-1077.
Harrigan G.G., Luesch H., Yoshida W.Y., Moore R.E., Nagle D.G. and Paul V.J. 1999. Symplostatin 2 a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides. J. Nat. Prod. 62: 655-658.
Harrigan G.G., Luesch H., Moore R.E. and Paul V.J. 2000. The anticancer dolastatins as cyanobacterial metabolites. Spec. publ. R. Soc. Chem. 257: 126-139.
Harrigan G.G., Goetz G.H., Luesch H., Yang S. and Likos J. 2001. Dysideaprolines A-F and barbaleucamides A-B novel polychlorinated compounds from a Dysidea sp. J. Nat. Prod. in-press.
Jaspars M. and Lawton L.A. 1998. Cyanobacteria - a novel source of pharmaceuticals. Curr. Opin. Drug Discovery and Development: 77-84.
Jiménez J. and Scheuer P.J. 2001. New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 64: 200-203.
Kimura J., Takada Y., Goetz G., Nakao Y. and Scheuer P.J. 2000. The absolute stereochemistry of a new cyclic depsipeptide. In: 2000 Conference. Pacifichem, Honolulu, Hawaii, USA.
Kobayashi M., Kurosu M., Ohyabu N., Wang W., Fujii S. and Kitagawa I. 1994. The absolute stereostructure of arenastatin A, a potent cytotoxic depsipeptide from the Okinawan marine sponge Dysidea arenaria. Chem. Pharm. Bull. 42: 2196-2198.
Marner F.J., Moore R.E., Hirotsu K. and Clardy J. 1977. Majusculamides A and B; two epimeric lipopetides from Lyngbya majuscula Gomont. J. Org. Chem. 42: 2815-2819.
Moore R.E. 1996. Cyclic peptides and depsipeptides from cyanobacteria - a review. J. Industr. Microbiol. 16: 134-143.
Nakao Y., Yoshida W.Y. and Scheuer P.J. 1996. Pupukeamide a linear tetrapeptide from a cephalaspidean mollusk Philinopsis speciosa. Tetrahedron Letts. 37: 8993-8996.
Orjala J. and Gerwick W.H. 1996. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 59: 427-430.
Pettit G.R. 1996. Progress in the discovery of biosynthetic anticancer drugs. J. Nat. Prod. 59: 812-821.
Pettit G.R., Xu J., Hogan F., Williams M.D., Doubek D.L., Schmidt J.M. et al. 1997. Isolation and structure elucidation of the human cancer cell growth inhibitory cyclodepsipeptide dolastatin 16. J. Nat. Prod. 60: 752-754.
Reese M.T., Gulavita N.K., Nakao Y., Hamman M.T., Yoshida W.Y., Coval S.J. et al. 1996. Kululolide-a cytotoxic depsipeptide from cepahalaspidean mollusk Philinopsis speciosa. J. Am. Chem. Soc. 118: 11081-11084.
Skulberg O.M. 2000. Microalgae as a source of bioactive molecules-experience from cyanophyte research. J. Appl. Phycol. 12: 341-348.
Suenaga K., Nagoya T., Shibata T., Kigoshi H. and Yamada K. 1997. Dolabelides C and D cytotoxic metabolites isolated from the sea hare Dolabella auricularia. J. Nat. Prod. 60: 155-157.
Trimurtulu G., Ohtani I., Patterson G.M.L., Moore R.E., Corbett T.H., Valeriote F.A. et al. 1994. Total structures of cryptophycins, potent antitumor depsipeptides from the blue-green alga Nostoc sp. strain GSV 224. J. Am. Chem. Soc. 116: 4729-4737.
Unson M.D. and Faulkner D.J. 1993. Cyanobacterial symbiont biosynthesis of chlorinated metabolites from Dysidea herbacea (Porifera). Experientia 49: 349-353.
van Sande J., Deneubourg F., Beauwens R., Braekman J.C., Daloze D. and Dumont J.E. 1990. Inhibition of iodide transport in thyroid cells by dysidenin a marine toxin and some of its analogs. Mol. Pharmacol. 37: 583-589.
Yamada K., Ojika M., Ishigaki T., Yoshida Y., Ekimoto E. and Arakawa M. 1993. Apylronine A a potent antitumor substance and the congeners apylronines B and C isolated from the sea hare Apylsia kurodai. J. Am. Chem. Soc. 115: 11020-11021.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harrigan, G.G., Goetz, G. Symbiotic and dietary marine microalgae as a source of bioactive molecules–experience from natural products research. Journal of Applied Phycology 14, 103–108 (2002). https://doi.org/10.1023/A:1019570122349
Issue Date:
DOI: https://doi.org/10.1023/A:1019570122349